Papers

2

Total Citations

23

H-Index

2

About

Dr. Altan Omer is a pioneering urologic surgeon and researcher whose work sits at the critical intersection of surgical oncology and molecular imaging. His primary research focuses on advancing precision surgery for prostate cancer, with a particular emphasis on intraoperative fluorescence guidance and the clinical translation of novel imaging agents. Dr. Omer’s most significant contribution is his leadership of the first-in-human study of the PSMA-targeted minibody IR800-IAB2M for real-time fluorescence guidance during radical prostatectomy (2024, 18 citations). This landmark work demonstrated the feasibility of using a humanised, molecularly targeted probe to illuminate microscopic disease in the surgical field, representing a major step toward reducing positive margins and improving oncologic outcomes. Beyond his work in imaging, Dr. Omer has contributed to the understanding of rare coincident pathologies, as evidenced by his report of incidental lymphoplasmacytic lymphoma diagnosed following robotic prostatectomy (2019, 5 citations). His translational efforts bridge the gap between preclinical development and clinical application, establishing him as a key figure in the evolution of image-guided surgery for genitourinary malignancies.

Research Focus

Key Achievements

2
H-Index
2
Papers
23
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy
18 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Oxford University Hospitals NHS Trust, Lister Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago